Metropolitan Life Insurance Company (MetLife)’s Carlyle Group CG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,236
Closed -$178K 2321
2021
Q4
$178K Buy
3,236
+9
+0.3% +$490 ﹤0.01% 2106
2021
Q3
$153K Sell
3,227
-130
-4% -$6.23K ﹤0.01% 2279
2021
Q2
$156K Buy
3,357
+385
+13% +$16.4K ﹤0.01% 2327
2021
Q1
$109K Buy
2,972
+47
+2% +$1.65K ﹤0.01% 2390
2020
Q4
$92K Sell
2,925
-40
-1% -$1.13K ﹤0.01% 2392
2020
Q3
$73.1K Sell
2,965
-52
-2% -$1.4K ﹤0.01% 2384
2020
Q2
$84.2K Buy
+3,017
New +$77.5K ﹤0.01% 2356

Other funds holding CG

Metropolitan Life Insurance Company (MetLife)'s CG Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Carlyle Group (CG) in Q1 2022, closing a stake of 3,236 shares — an estimated $178K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CG in Q2 2020 and held it in 7 quarters. The position peaked at $178K in Q4 2021. 486 funds tracked by Wall St. Rank hold CG as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Carlyle Group position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,236 Carlyle Group shares in Q1 2022, an estimated $178K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Carlyle Group in Q2 2020 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Carlyle Group position peaked at $178K in Q4 2021.
  • 486 funds tracked by Wall St. Rank held Carlyle Group as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.